Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biocorrx Inc (BICX)

Biocorrx Inc (BICX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,633
  • Shares Outstanding, K 13,100
  • Annual Sales, $ 90 K
  • Annual Income, $ -3,770 K
  • EBIT $ -5 M
  • EBITDA $ -4 M
  • 60-Month Beta 0.60
  • Price/Sales 62.19
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.52
  • Most Recent Earnings $-0.14 on 11/14/24
  • Next Earnings Date 11/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3000 +43.33%
on 12/10/24
0.5000 -14.00%
on 12/12/24
+0.0700 (+19.44%)
since 11/15/24
3-Month
0.3000 +43.33%
on 12/10/24
0.5000 -14.00%
on 12/12/24
-0.0700 (-14.00%)
since 09/13/24
52-Week
0.2820 +52.48%
on 08/21/24
1.5000 -71.33%
on 04/12/24
-0.4700 (-52.22%)
since 12/18/23

Most Recent Stories

More News
BioCorRx Featured on LiveNOW from FOX

ANAHEIM, CA, June 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 0.4300 (+1.78%)
BioCorRx to Present at the LD Micro Invitational XII on June 7th

ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 0.4300 (+1.78%)
BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting

Collaboration to create a synergistic treatment offering, combining BioCorRx’s MAT treatment program and 2B3D virtual reality technology Plans toward...

BICX : 0.4300 (+1.78%)
BioCorRx Business Update for the First Quarter of 2022

ANAHEIM, CA, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire  – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 0.4300 (+1.78%)
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's...

CHL.AX : 0.680 (-2.86%)
DCM : 25.60 (-1.35%)
DDDX : 0.0110 (unch)
AAT.VN : 0.015 (unch)
AATGF : 0.0450 (+4,400.00%)
ASTR.VN : 0.130 (-3.70%)
AMI.VN : 0.135 (unch)
AUUD : 0.4764 (-8.12%)
AYRO : 0.7100 (-5.33%)
BNXA.VN : 0.940 (+25.33%)
BNXAF : 0.6515 (+20.65%)
BICX : 0.4300 (+1.78%)
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 0.4300 (+1.78%)
BioCorRx to Present at the Planet MicroCap Showcase 2022 in Las Vegas on May 4th

ANAHEIM, CA / ACCESSWIRE / April 26, 2022 / BioCorRx Inc. (OTCQB:BICX) (the "Company"), a developer and provider of innovative treatment programs fr substance abuse and related disorders, today announced...

BICX : 0.4300 (+1.78%)
BioCorRx Announces Additional Award of Nearly $100,000 from NIDA for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder

ANAHEIM, CA, April 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 0.4300 (+1.78%)
BioCorRx Provides 2021 Year-End Business Update

ANAHEIM, CA, April 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative...

BICX : 0.4300 (+1.78%)

Business Summary

BioCorRx Inc. is a healthcare solutions development company. It treats alcoholism and opioid addictions. The company's addiction treatment program consists of BioCorRx(R) Recovery Program. BioCorRx Inc. is headquartered in Santa Ana, California.

See More

Key Turning Points

3rd Resistance Point 0.5100
2nd Resistance Point 0.4700
1st Resistance Point 0.4500
Last Price 0.4300
1st Support Level 0.3900
2nd Support Level 0.3500
3rd Support Level 0.3300

See More

52-Week High 1.5000
Fibonacci 61.8% 1.0347
Fibonacci 50% 0.8910
Fibonacci 38.2% 0.7473
Last Price 0.4300
52-Week Low 0.2820

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar